He aha ke kumu o ka ʻaihue e lawe ai ʻo Telmisartan a pehea e hiki ai iaʻu ke hoʻololi i ka lāʻau lapaʻau?

Hiki i ke hypertension arert ke ʻano o ke ʻano me ka hoʻonui pinepine i ke kahe o ke koko, i ka waiwai o ka mea i ʻoi aku i nā helu 140/90 mm RT. ʻAniā. ʻO kēlā ʻano maʻi maʻi i hana ʻia i ka mea maʻi, hoʻolako ʻia e ʻike ʻia ke kiʻekiʻe o ke koko kiʻekiʻe ma ʻekolu o kona ana ana, i hana ʻia i nā manawa like ʻole a me ke kūpaʻa ʻana o ka wahi mālie. I kēia hihia, he mea koʻikoʻi loa ia ma mua o kēlā mau ʻano.

ʻO ka ʻike nui o ka maʻi

ʻO wai ka ʻeha pinepine i hōʻike ʻia i ka hypertension arterial? Wahi a nā poʻe loea, ʻike ʻia kahi maʻi like ma kahi o 30% o nā poʻe ʻelemakule a me waena loa, ʻoiai ʻo ka hoʻomohala ʻia o nā ala like like ʻaʻole i hoʻokaʻawale ʻia i nā wā ʻōpio. Pono e hāmama ʻia ka hapa like o ka nui o ka hōʻuluʻulu wahine a me nā kāne.

I waena o nā ʻano o ka hypertension arterial, maloʻo a hōʻemi i ke kiʻekiʻe kiʻekiʻe no ka nui o 80%.

ʻO nā ʻōwili, nā maʻi maʻi

ʻO ka hypertension Arterial he pilikia koʻikoʻi a maʻi olakino. ʻO ka nele o nā kūpono kūpono a kūpono i ka maʻi like ʻole e hiki i ka hoʻopiʻi ʻana i nā hōʻeha koʻikoʻi a me nā pilikia. Hoʻopili kēia i ka hōʻeha a me ka myocardial infarction, kahi e hiki ai i kahi kanaka ke nalo i ko lākou hiki ke hana, a me ka make.

ʻAʻole hiki ke ʻōlelo ʻia he alaka i ka hala a i ʻole ka hala o ka hypertension arterial e alakaʻi i ka hōʻino nui i nā arterioles o kekahi mau kino (no ka laʻana, ka maka, ka lolo, a me ka puʻuwai) a me ka hala ʻole o kā lākou hoʻokahe koko.

Hiki ke ho'ōla ʻia ka hypertension arterial? ʻO ka Therapy o ia maʻi e pono ke kuhikuhi pono i ka hoʻomaʻamaʻa ʻana i ke koko kiʻekiʻe. Eia naʻe, ʻaʻole i pau ka hopena ma laila. Me ka lawe ʻana i nā lāʻau lapaʻau e hoʻohaʻahaʻa i ke koko, pono kahi hoʻoponopono hoʻoponopono i nā maʻi āpau i loaʻa i nā hanana o loko.

Ua ʻōlelo ʻia nā poʻe loiloi he maʻi maʻamau ka maʻi nīnau. He mea pono ʻole ke manaʻolana no ka ho'ōla hou ʻana i ia mau hihia, akā hiki ke hoʻopili pololei ʻia ka mālama ʻana i ka hoʻomohala ʻana ma hope, a me ka hōʻemi nui ʻana i nā hōʻeha koʻikoʻi, me nā hihia kuhi hypertensive.

ʻO ke lāʻau lapaʻau pinepine pinepine ʻia no ka hypertension? ʻO ka lāʻau lapaʻau kaulana loa no kēia maʻi ʻo Telmisartan. Nānā ʻia nā ʻōlelo aʻoaʻo no ka hoʻohana ʻana, nā loiloi e pili ana i kēia lāʻau lapaʻau, kona ʻano, nā hopena ʻokoʻa, nā contraindications a me nā ʻike hou aʻe.

ʻO ka weheweheʻana i ka lāʻau lapaʻau, hoʻopili, ka mea hoʻonohonoho a me ke ʻano o ka hoʻokuʻu

Ma ke ʻano hea ka hoʻokuʻu i ka lāʻau "Telmisartan"? Hoʻomaopopo nā loiloi hoʻomanawanui ma ka maʻamau o nā lāʻau lapaʻau e hiki ke loaʻa nā lāʻau lapaʻau i ke ʻano o nā pōʻai a me nā papa mokulele-cylindrical o ke keʻokeʻo a i ʻole me ka huinahalike, a me ka hopena me ka chamfer.

ʻO ke ʻano ikaika o kēia lāʻau lapaʻau ka telmisartan. ʻO nā poʻe hoihoi, a laila e like me ka ʻāpana o nā papa.

• Nā meglumine
• lactose monohala ((a waiu waiu),
• sodium hydroxide
• sodium polio
• povidone K25,
• paʻahau magnesium.

Wahi a nā loiloi, "Telmisartan" i loko o nā papa i kūʻai ʻia aku ma nā mea kanu i loko o nā ʻāpana o nā contour, i waiho ʻia i loko o nā pūʻulu o nā kāleka.

Lapaʻau

He aha ka lāʻau lapaʻau "Telmisartan" (40 mg)? Hōʻike nā loiloi o ka poʻe loea i kēia lāʻau lapaʻau antihypertensive, he antagonist o nā ʻano AT1 ʻae, ʻo ia ka, angiotensin II. ʻO ka mākaukau i ka nīnau he pilina pili kiʻekiʻe no ka subtype receptor. He koho ia a luhi loa no ka nemo i ka angiotensin II, a ma hope o ka neʻe ʻana o ka mea ikaika me ka ʻāʻeu me nā ʻĀpana AT1.

Nā hiʻohiʻona ʻē aʻe

He aha nā waiwai ʻē aʻe i hoʻoili ai iā Telmisartan? Hōʻike nā loiloi ʻaʻole e pili ka mea ikaika o kēia lāʻau i ka ACE a me ka renin ma kekahi ʻaoʻao, ʻaʻole hoʻi e pale i nā kahawai e kuleana ana i ka lawe ʻana i nā papa.

Ua hoʻemi ʻia ka lāʻau lapaʻau i ka nui o ka ald testosterone i loko o ke koko. ʻO kahi papa lāʻau o 80 mg e hoʻopau piha i ke koko kiʻekiʻe i kumu ʻia e ka angiotensin II.

Hoʻomaopopo ka hopena therapeutic ma hope o ka lawe ʻana i ka pōkole e pili ana i kahi lā, a laila hoʻemi iki ʻia. Pono e hoʻomaopopo ʻia he hopena nui ka hopena o ka lāʻau lapaʻau ma ka liʻiliʻi ʻelua mau lā ma hope o ka hoʻomaka ʻana o ka hoʻomaʻamaʻa.

Wahi a nā loiloi, hiki i ka Telmisartan ke hoʻohaʻahaʻa i nā systolic a me ka diastolic pressure. Akā naʻe, ʻaʻole pono ka mea lapaʻau i ka hopena o ka puʻuwai o ke kanaka. Eia kekahi, ma ke ʻano o ka mālama ʻana, ʻaʻole i mālama ʻia ka hopena o ka hoʻohui a me ka hōʻiliʻili nui o ka mea ikaika o ka lāʻau i loko o ke kino.

Pharmacokinetic waiwai o ka lāʻau

He aha nā hiʻohiʻona pharmacokinetic o ka lāʻau lapaʻau Telmisartan? Hoike mai nā ʻōlelo a me nā loiloi o nā poʻe loea i ka wā e lawe ai i ka lāʻau i loko, e hoʻihoʻi ka mea ikaika mai ka digestive tract. ʻO ka bioavailability o kahi ma kahi o 50%.

Ke hoʻohana pū nei i ka lāʻau i ka wā like me ka meaʻai, ʻokoʻa ka hoʻēmi ʻana o AUC ma waena o 6-9% (ma kahi iki o 40-160 mg, kēlā).

I hoʻokahi mau hola ma hope o ka lawe ʻana i ka lāʻau lapaʻau, ʻoi ke kūlike o ka neʻe ʻana o ka hana ikaika i ka plasma koko (me ka manaʻo o ka lāʻau ua lawe pū ʻia me ka meaʻai a i ʻole ka ʻōpū ʻole).

ʻO ka pilina o telmisartan me nā protein protein e pili ana i ka 99.5%. Hoʻopili kēia mea hoʻohua ma o ka conjugation me nā waikawa glucuronic. I kēia hihia, ua hoʻokumu ʻia nā metabolacoreically inactive.

ʻO ka hapalua o ke ola o ka lāʻau i nīnau ʻia ai ma mua o 20 mau hola. Hoʻopili ʻia kāna mea ikaika e ka nāhelehele o nā ʻawaʻawa. ʻO ke kāpili Cumulative ma o ka ʻōnaehana kūwili e pili ana i ka 1%.

Nā hōʻailona no ka koho ʻana o ka lāʻau lapaʻau

I nā hihia hea ke ʻano o ka lāʻau lapaʻau e like me ke ʻano o Telmisartan? Hōʻike nā loiloi o nā kauka i hoʻohana ʻia ka lāʻau lapaʻau i ka wā i ka wā o ka mālama ʻana i ka maʻi hypertension. Hiki iā ia ke kau pū no ka pale ʻana i ka make mai nā ala i ke ʻano o ka pūnaehana cardiovascular, me ka hoʻopili ʻana i ka puʻuwai puʻuwai, ka maʻi o ka maʻi maʻi, a me ka maʻi o ka ventricular hypertrophy.

Palapala no ka hooponopono waha

I ka hea ʻoe e hoʻohana ʻole ai i nā papa Telmisartan? Nā hōʻike ʻana o nā loea, e like me nā ʻōlelo aʻo no ka hoʻohana ʻana i kēia lāʻau lapaʻau, e hōʻike i kēia mau contraindications no ka hoʻohana ʻana:

• maʻi hōʻaila pili hala
• konohukula
• uhaiki ikaika
• pilikia hanalei,
• frolose intolerance,
• ka maʻi paʻakikī o ka mea maʻi i ka mea nui a me nā mea ʻē aʻe o ka lāʻau,
• wā hāpai
• makahiki ʻokoʻa
• ka wā aloha.

Nā ʻōkuhi no ka hoʻohana

Pehea wau e hoʻohana ai i Telmisartan (40 mg)? Hōʻike nā loio o nā kauka e pono ke lawe i nā papa i ʻōlelo ʻia ma ke ʻano maʻamau (me ka ʻōlelo maʻamau), me ke ʻano o ka komo ʻana o ka meaʻai.

Ke hoʻoholo nei i ka hypertension arterial, ʻōlelo pinepine ʻia ka lāʻau lapaʻau i ka nīnau ma ke ʻano he 40 mg hoʻokahi i ka lā. Eia nō naʻe, i kekahi mau hihia, e hiki ke hoʻokaʻawale ʻia ka nui o ka lāʻau (i hāʻawi ʻia ua maikaʻi nā lāʻau i loko o kekahi nui o 20 mg).

Inā, ʻoiai e lawe ana i ka 40 mg o ka lāʻau, ʻaʻole i loaʻa ka hopena i makemake ʻia, a laila ua hoʻonui ʻia ka pona e piʻi i ka nui o 80 mg. I kēia hihia, ʻo kā noi ʻana o ke ʻano holoʻokoʻa ka hana ma mua o ka manawa.

Ke hoʻoponopono nei i ka mālama ʻana, pono e noʻonoʻo ka hopena ʻaʻole i loaʻa koke ka hopena therapeutic, akā ma hope o 1-2 mau mahina (e pili ana i ka hoʻohana ʻana i nā papa maʻamau).

No ka hōʻemi i ke koko, ʻo Telmisartan (80 mg), nā loiloi o nā mea e hōʻike ʻia ma lalo nei, ua kuhikuhi pinepine ʻia me ka thiazide diuretics.

ʻO ka lawe ʻana i ka lāʻau lapaʻau no nā maʻi cardiovascular

ʻO ka hopena o nā papa Telmisartan i hoʻohanaʻia e pale i ka make ma nā mea maʻi me nā pilikia cardiovascular e nānā ma kahi o ka 80 mg i kēlā me kēia lā. Inā ʻike ʻia kahi hopena like ma nā wahi haʻahaʻa haʻahaʻa.

I nā maʻi o nā pēpē a me nā puʻupaʻa, pono pono ke hōʻoia i ka nui o ka lāʻau i hōʻike ʻia ʻaʻole i hoʻonāukiuki i ka hoʻomohala ʻana o nā hopena ʻaoʻao mai nā mea i ʻōlelo ʻia. No laila, i kēlā mau kūlana, ua pono e hoʻomaka i ka mālama ʻana me kahi maʻi o 20 mg i kēlā me kēia lā. Pono e noʻonoʻo ʻia i ka hapanui o nā kānaka me ka hana kapili o ka puhaka, kahi pākuʻi ma luna o 40 mg o kēlā me kēia lā ka pilikia.

Nā hopena hopena

He aha nā hopena kūpono e hiki ai i ka lāʻau lapaʻau Telmisartan 80? Hōʻike nā loiloi o ka poʻe loea i ʻike i nā hanana lē maikaʻi i ka hope o ka lawe ʻana i ka lāʻau lapaʻau i ka nīnau he mea ʻemi loa. Eia nō naʻe, i kekahi mau hihia, ʻōhumu hou nā maʻi i nā ʻano i lalo iho:

1. Bradycardia, anemia, pōkole o ka hanu, ka luaʻi ʻana, ke kiʻekiʻe o ka creatinine i loko o ke koko, nā moe hiamoe, ʻehaʻeha, ʻeha hoʻi.
2. Nā kūlana kaumaha, dyspnea, vertigo, spasms o nā keiki bipi, nāwaliwali, nā ʻūwili o ka ʻili, ke kīwaha i ke kahe o ke koko, ʻeha i loko o ka ʻōpū, nā nāwaliwali.
3. ʻO ka Dyspepsia, rashes, ʻoi aku ka hopena o ka renal, ka hyperkalemia, ka ʻeha o ka ʻōpū, nā hana hōʻeha o ka pale, hoʻonui nui.
4. ʻO ka ʻehaʻeha o ka naʻau, nā mea hanu a me nā maʻi urinary tract (e.g., cystitis, sinusitis, a i ʻole pharyngitis), tachycardia, sepsis, nā haunaele ʻike, thrombocytopenia, a me ka waha maloʻo.
5. Hōʻemi ka ʻogogobobin, ʻehaʻeha, hopohopo, hōʻeha i ka ʻōpū, hoʻemi i ke koko i ka wā e hoʻololi ai i ke kūlana o ke kino, huʻule ka hana a me ke ʻano, erythema, hoʻonui i nā ʻano o nā huina o nā ate, ka pīhoihoi o ka ekzematous, hoʻonui i ka nui o ka wa uric i ke koko.
6. ʻO ka ʻeha o Tendon, angioedema, tendonitis, raches rashes, hoʻonui i nā kiʻekiʻe o nā eosinophils.

He mea nui ia e ʻike!

Me ka nui o ka makaʻala, ua hoʻokaʻawale ʻia ka lāʻau Telmisartan no ka hana aho ʻole, ka stenosis aortic, ulia gastric a me ka ulalā duodenal (i ka wā exacerbation), ka maʻi naʻau coronary, nā maʻi kūwaho, stenosis mitral valena, ka puʻuwai naʻau, a me ka hypomyrophic obstract cardiomyopathy.

ʻO ka poʻe me ka hoʻohaʻahaʻa BCC, me ka hyponatremia hoʻi, hoʻomohala i ka hypotension hypertension (me ke ʻano ma hope o ka lawe ʻana i ka pill mua o ka lāʻau). I kēia mea, ma mua o ka mālama ʻana e pono ai ke hoʻoponopono ʻana i kēia mau kūlana.

Ke pāpā ʻole ʻia nei e hoʻohana i ka telmisartan i nā maʻi me nā aldosteronism prim.

Hiki i ka hoʻohana ʻana i ka lāʻau lapaʻau me ka hui pū me ka diuret thiazide, no ka mea, he hui like ʻole ia i ka nui o ke kahe o ke koko.

ʻO ka lāʻau mai ke kiʻekiʻe o ke koko "Telmisartan": loiloi a me nā analogues

ʻO ke ʻano o nā lāʻau lapaʻau i ka nīnau ʻia nā ʻano penei:

Ma mua o ka hoʻohana ʻana i kēia mau lāʻau lapaʻau i mea e hoʻopau ai i ka hypertension arterial, pono e noʻonoʻo ʻia ua loaʻa ko lākou mau ʻano pharmacological ʻano, nā hopena ʻaoʻao a me nā contraindications.

Pehea ka maikaʻi o Telmisartan? Loaʻa nā loiloi e pili ana i kēia lāʻau lapaʻau. I kēlā mau hōʻike i ʻike ʻia i kēia lā, he 80% ka maikaʻi. Ke kuhi nei ka poʻe e hōʻemi nei i ka hoʻonui pinepine ʻia e ka lawe ʻana i nā papa i haʻi ʻia iā ʻoe e wikiwiki wikiwiki a me ka maʻalahi me ka maʻalahi. Eia nō kekahi, ʻoluʻolu nā poʻe maʻi me ka ʻike ʻole ʻia e kēia lāʻau lapaʻau i nā hopena ʻaoʻao.

ʻO nā huahana Pharmacological o Telmisartan

Loaʻa i ka Telmisartan (telmisartan) nā mana antihypertensive maikaʻi, e kōkua i nā mea maʻi i ka pilikia pilikia e hiki ke hoʻololi pono i ka pae arterial. ʻO ka lāʻau lapaʻau kahi ʻelele o ka hui lāʻau e pili ana me ka angiotensin 2 antagonist receptor.

Loaʻa kona hopena kikoʻī:

1. Loaʻa i ka hiki ke koho a me ka hoʻomau mau i nā ʻae i nā mea kūikawā, e hoʻowalewale i ka angensensin 2, a laila ke pale aku nei i kona pilina me ka mea hoʻopili o ka ATC 1, ʻaʻohe ona mau ʻano o kahi agonist ma ke ʻano o kēia kākena.
2. Hiki iā ia ke hana i kahi pili mau loa me ka ATP 1 angiotensin 2 receptors.
3. ʻAʻohe hopena i nā receptors angiotensin ʻē aʻe.
4. Hoʻemi i ka helu o ka aldetorene i ke ola koko.
5. ʻAʻole e keʻae i ka bradykinin.
6. ʻAʻole ia e pale i ka hana a ka renin, nā kahe a me ka ACE.

He mea kūpono ia e ʻike ai i kēia mau ʻano kūpono o ka huahana:

• ʻO Telmisartan ma ke ʻano o 80 mg kaomi i ka mana hypertensive o ka angiotensin 2 maikaʻi.
• ʻO ka hopena therapeutic o ka lāʻau lapaʻau ka lōʻihi o 24 mau hola a lōʻihi i nā lā ʻelua.
• Hoʻomaopopo ka hopena antihypertensive koʻikoʻi 3 mau hola ma hope o ka lawe ʻana i ka paila, a ʻike ʻia ka hopena therapeutic kiʻekiʻe ma hoʻokahi mahina ma hope o ka hoʻomaka ʻana o ka papa hana.
• Me ka hana koʻikoʻi o ka lawe ʻana iā Telmisartan, piʻi i ke kahe koko i nā hōʻailona kumu ʻole me ka ʻole o nā hōʻailona o ka haʻalele ʻana.
• Ma lalo o ka hopena o ka lāʻau lapaʻau, aia ka emi o ke kaumaha o ka ventricle hema i nā poʻe me ka ventricle hema a me hypertension.

ʻO ka hiʻohiʻona o ka lāʻau lapaʻau

ʻO ka hana koʻikoʻi o ka lāʻau lapaʻau ka telmisartan, aia ma 1 papa ma nā ʻano ʻē aʻe.

E like me nā mea hoʻohui aʻe i ka ʻano o nā papa.

• Nā meglumine
• sorbitol
• povidone
• hoihoi
• konekena stearate,
• haniailahion,
• sodium hydroxide.

Uila a me ke ʻano o ka hoʻopuka

Loaʻa ka lāʻau lapaʻau nui Telmisartan i ka puka lāʻau wale nō - tablet papa. ʻO nā paila he oblong ka hoʻonohonoho ʻana me kahi wī no ka wāwahi a keʻokeʻo a keʻokeʻo paha ia.

Pono e kikoo i nā nuances koʻikoʻi:

1. Loaʻa i ka Telmisartan ma ke kau inoa wale nō.
2. ʻO nā ola papa papa i nā makahiki he 3 mai ka lā o ka hana.
3. Nā wahi mālama - i ke ana o ka lōʻihi o 25 mau kekelē ma kahi e hiki ʻole ai ke keiki.
4. Ke mālama nei i nā paila, hoʻokaʻawale i ka hiki o ka lā maka.

He kumukūʻai ke kumukūʻai o nā lāʻau lapaʻau ma luna o ka ʻāina o ka hana. ʻO ke kumukūʻai kiʻekiʻe o Telmisartan mai nā mea hana ʻē aʻe:

• Ukraine - 220 rubles.
• Slovenia - 900 nā rubles.
• Turkey - 350 rubles.

ʻO nā maʻi i hōʻike ʻia i ka lāʻau?

Hoʻomaopopo ʻia ʻo Telmisartan ma ke alo ʻana i kēia mau maʻi hōʻeha:

• No ka mālamaʻana i ka hypertension koʻikoʻi i nā pākeke.
• No ka pale ʻana o nā maʻi naʻau a me nā maʻi vascular i nā maʻi me nā maʻi diabetes type 2.
• ʻO nā mea maʻi me ka maʻi nui o ka cardiovascular atherothrombotic (stroke, pathology of peripheral arterial vessel, coronary heart disease).

Nā hoʻohālikelike a me nā pale i kau ʻia

Hōʻike ka hōʻike ʻana iā Telmisartan he nui nā contraindications, no laila pono ʻoe e makaʻala i ka wā e lawe ai e kāpae i nā hopena maikaʻi ʻole. Ma keʻano kūikawā, ʻaʻole i kuhikuhi ʻia i nā poʻe maʻi e:

• Kahawai
• Hoʻokaumana.
• Kahihewa o ka palaki biliary.
• Allergy i ka telmisartan.
• Ke hoʻomanawanui nei i ka fructose a i ʻole nā ​​mea ʻē aʻe o ka lāʻau lapaʻau.

Eia kekahi, pono e mālama pono ʻia i kēlā mau mea maʻi i loaʻa kahi mōʻaukala o nā alahele a i ʻole nā ​​kūlana o ke kino.

• Holoiuhi maʻi
• He maʻi maʻi nā neʻe Coronary.
• Nā maʻi gastrointestinal.
• Na keiki malalo o na makahiki 18.
• ʻO ka stenosis valve Mitral a aorta.
• Nā maʻi puʻuwai.
• Hōʻike i ka hypomyrophic cardiomyopathy.
• ʻŌpū o ke ʻōpū a me ka duodenum.

E pili ana i nā nuances e like me kēia:

1. ʻO nā mea maʻi me ka renal dysfunction ʻoiai e lawe ana i ka lāʻau e pono e nānā mau ʻia no ka creatinine a me ka potassium.
2. I mua o ka stenosis bilateral o nā moku arapi hepatic a i ʻole ka hoʻopili ʻia o nā ʻalika o ka renal me kahi keiki hana hoʻokahi, ʻo ka hoʻohana ʻana i kēia lāʻau lapaʻau ka nui o ka ʻeha o ka hypotension a me kahi hana ʻole.
3. Pono nā wahine e hoʻolālā nei i kahi hāpai i ka lawe ʻana iā Telmisartan, ke hoʻololi nei iā ia me ka lāʻau lapaʻau me nā mea hoʻohālike like.
4. Ma muli o ka lawa ʻole o ka ʻike e pili ana i ka hiki ʻana o nā mea waiwai e komo ana i loko o ka waiū umauma, pono e pale nā ​​makuahine hūnā me ka hoʻohana ʻole i ka lāʻau.

Eia kekahi, inā he mau mea pono ʻole o ke kanaka ma ke kino, pono ʻoe e hoʻomaopopo i kāu kauka e pili ana i kēia:

• Naʻi maʻi mellitus.
• Maʻi maʻi.
• Nā kuʻuna o nā keiki.
• Nā maʻi gastrointestinal.
• Ke lawe nei i nā lāʻau lapaʻau ʻē aʻe.
• Ke hoʻohana nei i nā lāʻau lapaʻau.
• Allergy i nā lāʻau lapaʻau.

Inā hoʻolālā ʻia ka hana hoʻokolohua i ka manawa o ka hoʻohana ʻana i nā papa, e hoʻomaopopo pono i ka hōʻike ʻana i ka mea maʻi e pili ana i kona komo.

ʻO nā hōʻailona āpau a me nā hōʻailona ʻaoʻao

Aia nā ʻōlelo no ka hoʻohana ʻana o Telmisartan i nā ʻike e pili ana i ka hopena maikaʻi loa i nā kino pilikino a me nā papa o ke kino kanaka. Eia nō naʻe, ua ʻike ʻia kēlā mau alana maʻi i loko o nā moʻolelo i hoʻokaʻawale ʻia, maʻamau ʻo ia kona mau ʻike me nā ʻano pilikino o ke kino.

Pehea e pili ai ka Telmisartan i ka hana Arterial

ʻO ka hopena olakino o Telmisartan ma luna o nā hana cardiac a me ka vascular ka ma kēia:

• Ke kāohi nei i ka hana o nā mea ʻona no ka angiotensin, e hoʻonāukiuki ai i ka lele ʻana o ke koko.
• Ma hope o ka hoʻopaʻa ʻana i kēia mau mea nānā, e hoʻonui ka vascular lumen, a laila e hoʻomaikaʻi ai i ke ʻano o ke kahe koko, e kōkua ana e hoʻohaʻahaʻa i ke koko.
• I nā maʻi maʻi hypertensive, e hoʻohaʻahaʻa ka Telmisartan i nā kumu kiʻekiʻe o ke koko a me ka puʻuwai haʻahaʻa me ka hoʻopono ʻole ʻana i ka puʻuwai a me ka puʻuwai puʻuwai.
• Hoʻomaʻamaʻa maikaʻi nā hāmeʻa intracranial me ka hōʻole ʻole i ka ritika puʻuwai.
• E like me ke hōʻike ʻana i ka hōʻike, hoʻoemi ka lāʻau i ka papa o nā hemahema o ka cardiovascular, ma laila e hōʻemi ai i ka hopena o ka make.
• E hōʻemi ana i ka puʻuwai a me ka hoʻoulu ʻana i ka naʻau.
• Pale ia i ka hoʻomohala ʻana o ka atherosclerosis a me ischemia, hoʻomaikaʻi i ke kahe koko i loko o nā moku peripheral.
• He maikaʻi ka hopena o ka lāʻau lapaʻau i ka hana koʻi.

Kahi kumu o ka lawe ʻana i ka lāʻau lapaʻau no ka pilikia pilikia

Pehea e lawe ai i ka telmisartan? Wahi a nā ʻōlelo kuhikuhi, pono e inu ka lāʻau i ka manawa 1 i ka lā i ka nui o 20-40 mg, ʻoiai:

1. E hoʻokō i ka hopena hypotensive no kekahi mau maʻi maʻi, 20 mg lawa.
2. Inā kūpono, e hoʻolaʻa ka lāʻau i kēlā me kēia lā i 80 mg.
3. ʻAʻole pono i nā maʻi o nā makahiki holomua a me nā poʻe me ka wehe ʻana i ka renal i ka hoʻoponopono kānāwai.
4. ʻO nā maʻi maʻi hypertensive me ka pilikia pilikia o ka hoʻomaka mua, ka lāʻau maʻamau o kēlā me kēia lā i ka nui o ka 40 mg.
5. Me ka pae mua o ka maʻi hypertension, ʻo ka nui o kēlā me kēia lā he 160 mg, a me ka hui pū ʻana me ka hydrochlorothiazide - 12.5-25 mg i kēlā me kēia lā.

ʻO ka lōʻihi o ke papa no ka mālama ʻana ma muli o ka hōʻeha o ka hypertension, no laila, hiki ke lilo i mau mau mahina a lawe ʻia e ka mea maʻi no ke ola. Loaʻa ka hopena therapeutic kiʻekiʻe ma hope o 4-8 mau pule mai ka hoʻomaka ʻana o ka lāʻau lapaʻau.

Pau ʻole ia ke hoʻololi kūʻokoʻa ʻana i ka nui o nā lāʻau lapaʻau a kāpae i ka mālama ʻana me ka ʻole i ʻae ʻia e ke kauka.

Nā hiʻohiʻona o ka pilina me ka meaʻai a me ka waiʻona

ʻO ke kūlike o ka hopena o ke kelepona o Telmisartan kahi kūʻokoʻa o ka mālamaʻai meaʻai. Wahi a nā poʻe loea, ʻoiai ke lawe nei i ka pālule me ka meaʻai, aia ka liʻiliʻi i nā mea antihypertensive o ka lāʻau lapaʻau, ʻaʻole i hopohopo i kāna mau lāʻau lapaʻau.

• Dosis 40 mg - mai 6%.
• Dose 160 mg - a i ka 19%

Eia naʻe, 3 mau hola ma hope o ka lawe ʻana i ka lāʻau lapaʻau, hoʻonui ka nui o nā mea nui o ka lāʻau lapaʻau, me ka ʻole o kona hoʻohana - i ka manawa like me ka meaʻai a ma luna o ka ʻōpū ʻole.

E pili ana i ka hoʻopili ʻana o ka lāʻau lapaʻau me nā mea inu wai ʻawaʻī, ʻo Telmisartan a me ka waiʻona ua hoʻohālikelike ʻole ia. Hoʻonui ka Ethanol i ka hopena o ke telmisartana, hiki iā ia ke hōʻeha i ka piʻi nui o ke koko i nā pae koʻikoʻi. Eia kekahi, ʻo ka hōʻikeʻana o ka hypotension koʻikoʻi hiki ke hoʻonāukiuki i nā hoʻopiʻi pathological ʻē aʻe.

E hui pū me nā lāʻau lapaʻau pilikino

Ke mālama nei me ka Telmisartan, pono e noʻonoʻo nā mea maʻi hypertensive i kona hoʻopili ʻana me kekahi mau lāʻau lapaʻau, e kōkua ana i ka pale ʻana i ka hōʻike ʻana o kahi lapaʻau maikaʻi.

Hoʻohā ʻia ka Telmisartan e lawe ʻia me ka diuret th thiazide, ka mea i hāʻawi ʻia i ka emi o ke kahe koko i ka pae i koi ʻia.

ʻO nā hoʻohālikelike kikoʻī

I waena o nā mea kikoʻī o ka lāʻau Telmisartan, nona nā hiʻohiʻona antihypertensive kiʻekiʻe, ʻike ka poʻe loea:

1. Tanidol.
2. Telpres.
3. Telmisartan-C3.
4. Presartan.
5. Losartan.
6. Canon Losartan.
7. Keahi ka wahine.
8. Keola.
9. Mikardis.
10. Koiā ʻia.
11. Valsartan.
12. Kauhi.

ʻO ka hoʻohālikelike hoʻohālikelike me nā lāʻau like

ʻO ka hoʻohālikelike o nā kikoʻī maʻamau o Telmisartan - Valsartan a me Losartan:

Ua paʻakikī ka ʻōlelo ʻana i ka mea o kēia mau lāʻau ke manaʻo maikaʻi loa i ka ʻōlelo a ko lākou ʻano therapeutic, no ka mea, ʻo kahi kūlana kūloko e koi ana i kahi ala lāʻau lapaʻau.

Kūkulu ʻia kēlā me kēia mau lāʻau lapaʻau e ka cardiologist wale nō ma hope o kahi hōʻike kikoʻī o ke ala o ka hypertension a me nā hopena o nā diagnostics kino.

Hoʻohālikelike

No kā Kammisartan ka lālā lapaʻau o sartans. Mahalo i kona mau therapeutic kiʻekiʻe, kōkua ia i nā mea maʻi hypertensive e hoʻomaikaʻi maikaʻi i ke koko kiʻekiʻe.

Me ka hoʻopiʻi kūpono a me ka hoʻokō ʻana i nā ʻōlelo lapaʻau, pono ka lāʻau lapaʻau ʻaʻole i nā hopena ʻaoʻao. He mau palena o ka lāʻau lapaʻau no kona komo ʻana, no laila e pono ʻoe e noʻonoʻo pono i nā ʻōlelo pili i hoʻopili ʻia.

ʻĀpana Pharmacological

Hoʻomākaukau maʻalahi i nā antagonist angiotensin II. PBX code C09C A07.

Ke ʻano o ka hypertension pono i nā pākeke.

Kākoʻo o ka maʻi cardiovascular.

ʻO ka hōʻemi o ka loaʻa ʻana o nā maʻi cardiovascular ma ka maʻi me nā:

nā hōʻike koʻikoʻi o ka maʻi cardiovascular atherothrombotic (ka maʻi puʻuwai coronary, ka hōʻeha a me ka mōʻaukala o nā pono peripheral),

mellitus type II mellitus me ka maʻi ʻona kino huna.

ʻLoe a me ke kākele

Pono e hoʻohana ʻia ʻo Telmisartan-Teva hoʻokahi manawa i ka lā ma ka waha me ka nui o ka wai, me ka ʻole o ka komo ʻana o ka meaʻai.

Hoʻohana ʻia ka maʻi hypertension.

ʻO ka paipai ʻia e 40 mg i kēlā me kēia lā. No kekahi mau mea maʻi, he lawa ka nui o 20 mg i kēlā me kēia lā. Inā ʻaʻole e emi ka pae o ke koko i ka helu i makemake ʻia, a laila hiki iā ʻoe ke hoʻonui i ka nui i ka 80 80 mau manawa hoʻokahi i ka lā. Hiki ke kuhikuhi ʻia ka Telmisartan-Teva i hoʻohui pū me ka thiazide diuretics hydrochlorothiazide, ka nui o ka hopena hou o ke hoʻohaʻahaʻa i ke koko i ka wā i ʻōlelo ʻia ai me telmisartan. Ke hoʻoholo nei inā ʻoi e hoʻonui i ka pona, pono e hoʻomanaʻo i ka nui o ka hopena antihypertensive e hele mai ma hope o 4-8 mau pule mai ka hoʻomaka ʻana o ka mālama ʻana.

Kākoʻo o ka maʻi cardiovascular.

ʻO ka lāʻau i ʻōlelo ʻia e 80 mg 1 mau manawa i kēlā me kēia lā. ʻAʻole i ʻike ʻia e loaʻa ana kahi hapa o Telmisartan ma mua o 80 mg i ka hōʻemi i ke kiʻekiʻe o ka morbidity cardiovascular.

I ka hoʻomaka ʻana o ka mālama ʻana me ka telmisartan, i mea e hōʻemi ai i ka maʻi o ka maʻi cardiovascular, ua manaʻo ʻia e mālama pono i ke koko. Pono ia e hoʻoponopono kūpono i nā hiʻohiʻona o nā hoʻohana i nā lāʻau lapaʻau e hoʻohaʻahaʻa i ke koko.

Hola paʻa kino hana.

I nā poʻe maʻi me ka hōʻemi ʻole ʻana a me ka hoʻololi ʻana i ka renal, ʻaʻohe mea pono no ka hoʻoponopono hoʻoponopono ʻana. He kaupalena ka ʻike me ka hoʻohana ʻana i nā mea maʻi me ka maikaʻi ʻole a i ka hemodialysis. No kēia mau mea maʻi, ua ʻōlelo ʻia kahi emi haʻahaʻa o 20 mg.

Hōʻeha ka hana ʻoluʻolu.

No nā mea maʻi me ka hana o ka puʻuwai hemahema a hōʻemi i ke kiʻekiʻe, ʻaʻole pono ka nui o ka lāʻau i ka 40 mg i kēlā me kēia lā. I ka poʻe maʻi me ka pīhoihoi hana ʻino ʻeha, ua contraindicated ka lāʻau lapaʻau.

ʻO nā poʻe maʻi o nā makahiki kiʻekiʻe.

ʻAʻole pono ke hoʻoponopono ʻia.

E hoʻokuʻu i nā palapala a me ka ʻano

Loaʻa i nā palapala papa. ʻO ka hana koʻikoʻi o ka lāʻau lapaʻau ka telmisartan. Aia i hoʻokahi papa he 80 mg o ka mea hana, ke keʻokeʻo ma ka pena a me nā capsule-like. ʻAʻole palapa ʻia nā papa, pākahi ʻia kēlā me kēia me ka helu 80 ma kekahi ʻaoʻao.

E like me nā mea kōkua, sodium hydroxide, wai, povidone, meglumine, magnesium stearate a me ka hana mannitol.

ʻO Telsartan 80 kahi lāʻau lapaʻau e hoʻohana ai e mālama i ka maʻi hypertension a me nā ala ʻē aʻe.

Ka hana lāʻau lapaʻau

ʻO ka hopena antihypertensive o ka mea hana e hōʻoia ʻia e ka pale ʻana o ka antiagonistic o nā ʻāpana o nā ipu e hoʻonaninani i ka angiotensin 2. ʻO ka molekika telmisartan ka like me ka mea hanohano, no laila pili ʻia ia i nā mea i ʻae ʻia ma kahi o ka hormone, ke kāohi nei i kona hopena. ʻAʻole e hoʻonui ka leo vascular, ka mea e pani ai i ka piʻi o ke kahe koko.

ʻO ka hana koʻikoʻi o ka lāʻau lapaʻau ka mea e hoʻopaʻa ai i nā mea hōʻike i kahi lōʻihi. Characteristically, ʻae ʻia nā mea pale o ka sublipe AT1. Hoʻopaʻa kūʻokoʻa nā subtypes o nā receptor angiotensin. ʻAʻole i aʻo ʻia kā lākou kuleana kūpono i ke kino, no laila, ʻaʻole lākou e hoʻōki i ke kahe i ke koko.

Ma lalo o ka hopena o ka lāʻau, hoʻopau ka hana o nā aldoster free. I ka manawa like, like ka nui o ka renin i like. ʻAʻole kīpī nā wahi o nā membrane pili i nā kaomi ʻona.

ʻAʻole ʻo Telsartan kahi angiotensin e hoʻohuli ana i ka inhibitor enzyme. ʻO kēia ke hiki ʻole i kekahi mau maki like ʻole e hōʻino, no ka mea, ʻo kēia enzyme ke kuleana no ka ʻaki o ka bradykinin.

Lapaʻau lāʻau

Me ka hoʻokele waha ʻana o ka lāʻau lapaʻau, hiki i ka mea hana ke hele i ka mucosa o ka pūpū liʻiliʻi. Ua aneane paʻa loa ia e lawe i nā peptides. ʻO ka hapanui e halihali ʻia me ka albumin.

ʻO ka huina piha o ka lāʻau lapaʻau e pili ana i ka 50%. Hiki i ke emi ʻana me ka lāʻau lapaʻau me nā meaʻai.

ʻO ka papa hana nui o ka metabolic hoʻololi o ka lāʻau lapaʻau i loko o ke kino ke ala o ka conjugation i glucuronide. ʻAʻohe o ka hopena hopena ʻaʻohe lāʻau lapaʻau.

Ke Hoʻohanohano TelsartanTelsartan H Kaukaʻi

ʻO ka hapa nui o nā mea hana e hoʻopiʻi ʻia i kāna palapala kumu. ʻO ka pau hoʻopau hapa-ola he 5-10 hola. Ke waiho nei ka mea hoʻohui i ke kino i ka 24 mau hola.

Nā hōʻailona no ka hoʻohana ʻana

Hoʻohana ʻia ka polokalamu no:

• therapy hypertension
• ka pale ʻana o ka make mai nā pathologies CVD i ka poʻe mai 55 mau makahiki he nui ka nui o ko lākou hoʻomohala ʻana ma muli o nā pilikia o ka ʻōnaehana cardiovascular,
• ka pale ʻana o nā hoʻopiʻi i nā maʻi me ka diabetes-mellitus-non-insulin mellitus i hōʻike ʻia me ka maʻi kino o loko e pili ana i ka maʻi lalo.

Pehea e lawe ai iā Telsartan 80

Hoʻopau ʻia nā peni i kēlā me kēia lā. Hiki iā ʻoe ke lawe ia ma kahi o ka manawa o ka pāʻina, me ka nui o ka wai.

ʻO ka maʻa mua he 40 mg. Inā ʻaʻole e ae ia ia kahi nui o ka lāʻau lapaʻau e hoʻomake i ke kaohi o ke kō o ke koko, e hoʻonui ʻia ka nui.

ʻO ka palena kiʻekiʻe loa o kēlā me kēia lā he 80 mg. ʻAʻole kūpono ka hoʻonui hou ʻana no ka mea ʻaʻole ia e hoʻonui i ka pono o ka hāmeʻa.

Pono e hāpai ʻia i ka hopena ʻole o ka hopena o ka lāʻau. Loaʻa ka hopena kūpono ma hope o 1-2 mau mahina o ka hoʻohana mau.

Hoʻohui pū ʻia ʻo Telsartan me nā diuretics thiazide. Hiki i kēia hoʻohui ke hoʻopiha hou i ka hoʻoikaika ʻana.

I nā hihia koʻikoʻi o ka maʻi hypertension, hiki iā ia ke kuhikuhi i 160 mg o telmisartan i hui pū me ka 12.5-25 mg o ka hydrochlorothiazide.

Me ka maʻi diabetes

Ma ke ʻano 2 diabetes mellitus, hiki ke lawe ʻia a Telsartan e pale ai i nā hoʻopiʻi vascular mai nā ʻōpū, puʻuwai, a me ka retina. Ua hōʻike ʻia ka lāʻau lapaʻau ma loko o kahi waihona ʻo 40 a i ʻole 80 mg, pili i ka paʻakikī o nā hōʻike o ka hypertension.

Lawe ʻia ka lāʻau ma luna o ka wā lōʻihi. Hōʻike nā haʻawina haukaʻi i ke koko o ka systolic a me ka diastolic e hoʻemi ana i ka 15 a 11 mm Hg i ka wā i lawe ʻia ai mai 8 a 12 mau pule. ʻAniā. ia wa.

Hiki i nā mea maʻi me ka maʻi diabetes a me ke hypertension ke hoʻohui pū me ka amlodipine. Hiki i kēia hoʻohui ke mālama i ka kiʻekiʻe o ke koko i loko o nā palena maʻamau.

Ma mua o ka lawe ʻana i ka lāʻau lapaʻau, pono ʻoe e kamaʻilio mau i ke kauka. Pono ke koho o ka maʻi a me ka lōʻihi o ke ʻano maʻi.

Pono pono e nīnau i ke kauka. Pono ke koho o ka maʻi a me ka lōʻihi o ke ʻano maʻi.

Hematopoietic mau hui

Mai nā kuhi he hemopoietic:

• anemia
• thrombocytopenia
• eosinophilia
• hōʻemi i ka pae hemoglobin.

ʻO kekahi o nā hopena ʻaoʻao o Telsartan o ka emi ʻana o nā pae hemoglobin.
ʻO ka ʻōnaehana o ka puni i ke kūlohelohe e pane i ka hoʻohana ʻana i ka lāʻau lapaʻau ma o ka loaʻa ʻana o ka insomnia.
Hōʻalo nā pilikia kaumaha ma lalo o ka mana o ka lawe ʻana iā Telsartan.
Hiki ke hoʻopiʻi ʻia ka maʻi maʻi e ka lawe ʻana i ka telsartan.
Hoʻomaʻamaʻa, luaʻi ʻia ka hopena ʻaoʻao o Telsartan.
Mai ka lawe ʻana iā Telsartan, ʻaʻole luhi ka hiamoe.
Ke ulu nei ka Flatulence ma muli o ka lawe ʻana iā Telsartine.

Ma ka ʻāpana o ka ʻili

Ma ka ʻāpana o ka ʻōnaehana hanu, hiki i ka telsartan ke hoʻoulu i ka ʻāʻī.
Hiki i ka ʻōnaehana musculoskeletal ke pane aku i ka mālama ʻana me Telsartan e ka ʻike o nā mea holo.Ma ka ʻāpana o ka ʻili, ʻo Telsartan ka mea hōʻeha a me ka ʻū.
Hiki i Telsartan ke hōʻeha i nā maʻi ʻeha.
Ke hoʻohana nei i ka telsartan, hiki paha i ka eczema.
ʻO ka Dermatitis e like me ka hopena o ka hopena me Telsartan.
Hoʻonui ka hoʻonui ʻana ma muli o ka lawe ʻana iā Telsartan.

Hoʻopilikia i ka hiki ke mālama i nā mīkini

ʻAʻole hana ʻia nā haʻawina o ka hopena o ka lāʻau i ka hiki ke mālama i nā mīkini. A ʻoi ʻia e kaupalena i ka manawa i holo ai ke kaʻa i ka wā e kū ʻia ai nā hōʻailona ʻaoʻao o ka pūnaehana nīnū.

I ka wā hoʻokolohua me Telsartan, ʻoi ʻia e hoʻopau i ka manawa i holo i ka kaʻa.

Nā ʻōlelo kikoʻī

Hiki i ka hypotension ke hele pū me ka hopena mua o ka lāʻau i nā mea maʻi me ka ʻole o ka nui o ke koko i hōʻemi ʻia ʻole nā ​​wai o ka sodium haʻahaʻa.

Hiki i kahi hypotension arterial hiki ke hele mai inā he maʻi stenosis val aʻa paha me ka puʻuwai naʻau congestive.

ʻAʻole maikaʻi ʻo Telmisartan i ka mālama ʻana i nā maʻi me ka hyperaldosteronism prim.

Me ka mālamaʻole, hāʻawi ʻia ka lāʻau lapaʻau i nā poʻe me ka stenosis o ka valve aortic a mitral paha.

Hiki i ka hoʻohana ʻana i ka lāʻau lapaʻau ke kumu i ka piʻi o ka nui o ka pāhana ma ke kahe koko. Hiki i kekahi mau kāne maʻi ke nānā aku i ka wā nānā i nā electrolytes plasma.

Aia ka hopena o ka hypoglycemia i nā poʻe e loaʻa ana i ka insulin a me nā lāʻau lapaʻau antidiabetic ʻē aʻe. Pono ia e noʻonoʻo pono i kēia ke koho ʻana i kahi ʻano o kēia mau lāʻau. Pono e kiaʻi mau i ka neʻe o ka glucose i ke kahe koko.

Nā hopena maikaʻiʻole

ʻO nā hopena koʻikoʻi koʻikoʻi, me ka hanana anaphylactic a me ka angioedema, hiki i kekahi mau hihia, ke nānā ʻole ʻia ka hopena o ka renal.

Nā maʻi hōʻeha a me nā maʻi hānai: nā maʻi lēpaʻi o ka ʻōpū hanu o luna (me ka pharyngitis a me ka sinusitis), nā maʻi lēpa o ka urinary tract (me ka cystitis), sepsis, me nā mea make o 1.

Ma ka ʻāpana o ke koko a me ka ʻōnaehana lymphatic: anemia, thrombocytopenia, eosinophilia.

Mai ka pānaʻi ʻana: ka hypersensitivity, nā hopena anaphylactic.

ʻO ka maʻi ma ka metabolic, ka maʻi metabolic: hyperkalemia, hypoglycemia (i loko o nā mea maʻi me ka maʻi mellitus).

ʻO nā maʻi noʻonoʻo: ke kaumaha, hoʻomālikelike, hopohopo.

Nā maʻi neurological: nāwaliwali, nā hiamoe.

Mai ka ʻaoʻao o ka io o ka hihiʻo: ʻike maka.

Ma ka ʻāpana o nā mea kūlohelohe a me ka apehu vestibular: vertigo.

Mai ka pūnaehana cardiovascular: bradycardia, tachycardia, hypotension arterial 2, orthostatic hypotension.

Mai ka pūnaehana hanu, umauma a me nā ʻōpū mediastinal: pōkole o ka hanu, pōkole, maʻiʻo interstitial.

Ua nānā iki ʻia nā pilikia o ka pūnāwai interstitial me ka telmisartan i ka wā nānā. Eia naʻe, ʻaʻole paʻa i kahi pilina kumu.

Mai ka ʻeha o ka gastrointestinal: ʻeha o ka ʻōpū, ka ʻōpū, ka dyspepsia, flatulence, luaʻi, ʻeha ma loko o ka ʻōpū, ka maloʻo maloʻo, dysgeusia.

ʻO nā hana a me nā mea wili. Ua hōʻike ʻia ʻo nā maʻi o ka lahui o Kepani i makemake hou i kēia mau ʻino.

Ma ka ʻāpana o ka ʻili a me ka kiko o ka subcutaneous: hyperhidrosis, itching, rash, erythema, angioedema (me nā hopena o ka mea make), dermatitis lāʻau, nā meaʻona dermatitis, eczema, urticaria.

Mai ka ʻōnaehana musculoskeletal a me ka kiko konohui: myalgia, ʻeha hope (no ka laʻana sciatica), nā ʻōpū o ke kino, arthralgia, ka ʻeha ma nā wāwae, nā ʻeha i nā tendons (hōʻailona tendonitis).

Mai ka pūnaehana urinary: hana renal impaired, komo me ka maikaʻi ʻole o ka renal failed.

ʻO nā maʻi maʻamau: ka ʻeha o ka umauma, asthenia (nāwaliwali), nā maʻi e like me ka maʻi maʻi.

Nā hōʻailona o ka hana Laboratory: kahi hoʻonui i ka hana i loko o ke koko, ke hoʻonui nei i ka nui o ka wa o ka uric acid i loko o ke koko, ke hoʻonui nui ʻana i nā pae o nā huina o ka huina, ka nui o ka pae o ka CPK i loko o ke koko, kahi hōʻemi i ka pae o ka hemoglobin.

ʻO ka wehewehe ʻana i kēlā me kēiaʻano kūlike maikaʻi

Sepsis. Ua hōʻike ʻia e loaʻa nā mea maʻi e lawe ana i ka telmisartan i kahi kiʻekiʻe o ka sepsis ma mua o nā mea i loaʻa i ka placebo. Hiki paha i kēia he ulia a i ʻole hōʻailona paha o ke kaʻina, kahi ʻike mau i ka ʻike ʻole ʻia.

Nā maʻi haipule. Hōʻike pinepine ʻia kēia ʻano ʻino i nā mea maʻi me ka neʻe koko i mālama ʻia me ka telmisartan e hoʻemi i ka maʻi cardiovascular ma ka hoʻohui ʻana i ka hana maʻamau.

Hōʻeha ka lawelawe kōpili / laupaʻa hepatic. Wahi a ka hōʻike kūʻai noiʻi, ʻo ka hapa nui o ka lawelawe ʻana o ka pehu a me nā maʻi o ka puʻuwai i nānā ʻia i nā poʻe maʻi o ka lahui Kepani. ʻOi aku ka maʻi o nā ʻōiwi Kepani i kēia hopena ʻino.

ʻO ka maʻi māmā interstitial. Ua nānā iki ʻia nā pilikia o ka pūnāwai interstitial me ka telmisartan i ka wā nānā. Eia naʻe, ʻaʻole paʻa i kahi pilina kumu.

1 ʻO kahi hoʻonui i ka ulu ʻana o ka sepsis i ka mālama ʻana i ka telmisartan ua hōʻike ʻia i hoʻohālikelike ʻia me ia i ka placebo. He hōʻike maoli ʻole paha ka hanana o kēia hanana a i ʻole e pili me kahi hana i ʻike ʻia i kēia manawa.

2 Ua hōʻike pinepine ʻia i nā poʻe maʻi me ka hoʻokahe koko koko i mālama ʻia me ka telmisartan e hōʻemi i ka morbidity cardiov a ʻoi aʻe i ka hana maʻamau.

Hoʻohana i ka wā hāpai a me ka lactation

Kahawai

Hoʻokomo ʻia ka lāʻau lapaʻau no nā wahine hāpai a i nā wahine paha e hoʻolālā ana i ka wā hāpai. Inā hoʻopaʻa ʻia ʻo ka hāpai ʻana i ka wā e mālama ai me ka lāʻau lapaʻau, pono e hoʻokaʻawale ʻia kāna hoʻohana a, inā pono, ke hoʻololi ʻia me kekahi lāʻau lapaʻau i ʻae ʻia no ka hoʻohana ʻana i nā wahine hāpai.

ʻAʻole lawa nā data i ka hoʻohana ʻana o telmisartan no nā wahine hāpai.

ʻO ke kumu epidemiological no ka hopena o ka teratogenicity ma muli o ka hoʻohana ʻana o nā inhibce ACE i ka wā mua o ka maʻa o ka hoʻomaka ʻana o ka hapai, ʻaʻole ia iʻike maoli ʻia, akā, i ka hopena i hōʻemi ʻia ʻole i hiki ke hoʻoholo ʻia. ʻOiai ʻaʻohe mea e hōʻike i ka hōʻike epidemiological e pili ana i ka hiki o ka teratogenicity me ka angiotensin II receptor antagonist, nā hopena like ʻole e pili ana i kēia papa o nā lāʻau lapaʻau. Ke hoʻolālā nei i ka hapai, pono e hoʻohuli hou ʻia ka lāʻau i mua me kekahi lāʻau lapaʻau antihypertensive i loaʻa ka palapala palekana palekana no ka hoʻohana ʻana i ka wā hāpai. I ka wā e hoʻomau ai ka male ʻana, pono e hoʻokaʻawale ke mālama me ka angiotensin II antagonist receptor a laila hoʻomaka ʻia ke ʻano lāʻau lapaʻau inā pono.

Ua ʻike ʻia ka hoʻohana ʻana o ka angiotensin II antagonist reseptor i ka wā o ka II a me III trimesters o ka hapai e hāpai i ka fetotoxicity i nā kānaka (kaʻai ʻana o ka hana renalous, oligohydramnios, lohi i ka hana o nā iwi cranial) a me nā meaʻeha o ka maʻi neonatal (renal failed, hypotension, hyperkalemia). Inā hoʻomaka ka hoʻohana ʻana o angiotensin II antagonist receptor i loko o ka lua o ka hapalua o ka hapai ʻana, e ʻōlelo ʻia e hana i ka nānā ʻana ka ultrasound o nā ʻōpū a me nā iwi o ka ʻōiwi. ʻO ke kūlana o nā pēpē i lawe ʻia e kona mau makuahine i ka anagonistin II receptor antagonist e nānā pono ʻia no ka hypotension arterial.

Haumakua.

No ka mea, ʻaʻohe ʻikepili e pili ana i ka hoʻohana ʻana o ka telmisartan i ka wā mālama i ka umauma, ʻaʻole i kuhikuhi ʻia kona hoʻohana ʻana a me nā ala e mālama ʻia me nā ʻaoʻao palekana e mālama ʻia i ka wā e hānai ai nā umauma, ʻoi aku hoʻi i ka wā e hānai ai i nā pēpē a i nā pēpi mua paha.

I ka wā o nā noi preclinical, ʻaʻohe hopena o ka telmisartan e pili ana i ka momona o nā kāne a me nā wahine.

ʻO ka hana pono a me ka palekana o ka lāʻau lapaʻau i nā keiki ma lalo o nā makahiki he 18 i hoʻopaʻa ʻole ʻia.

Nā hiʻohiʻona noi

Kahawai

I ka wā hapai, ʻaʻole hiki ke hoʻomaka ka mālama ʻana me ka angiotensin II antagonist receptor. Inā ʻaʻole hiki ke manaʻo ʻia ka hoʻomau i ka hana maʻi no ka mea maʻi e hoʻolālā nei i kahi hapai, pono ia e hoʻololi i ka anti antihypertensive therapy, i loaʻa iā ia kahi palekana palekana no ka hoʻohana i ka wā hāpai. Ke hoʻomau ʻia ka hapai, ʻo ka mālama ʻia ʻana o ka antagonist e pili ana i ka angiotensin II e hoʻihoʻi koke a, inā pono, pono e hoʻomaka ʻia nā ʻano maʻi (e nānā i nā Māhele "Contraindications" a "Hoʻohana i ka wā hāpai a me ka luhilahi.").

ʻAʻole pono e hoʻohana ʻia ʻo Telmisartan-Teva i nā mea maʻi me ka cholestasis, nā maʻi ʻeha o ka pūnaehao a me ka hoʻomaʻemaʻe nui ʻana o ka pūpū, ʻo ka telmisartan ka mea i hoʻohana nui ʻia ma ka bile. I ka poʻe maʻi me kēia mau maʻi, hoʻemi ʻia ka hoʻomaʻemaʻe hepatic o telmisartan. E hoʻohana i ka akahele ʻana i ka hoʻohana ʻana iā Telmisartan-Teva i nā mea maʻi me ka maʻi hānai i ke ʻano hepatic kūpono.

Aia ka hopena o ka hypotension arterial koʻikoʻi a me ka hana ʻole ʻole i ka poʻe maʻi me ka stenosis bilateral renal stenosis a i ʻole ka hana ʻana i ka maʻi stanosis ʻo kahi keiki hoʻokahi i ka wā e mālama ʻia me nā lāʻau lapaʻau e hoʻopilikia ai i ka renin-angiotensin-ald testosterone.

ʻO ka male ʻole a me ka hoʻololi ʻana i ka huehue.

Ke hoʻohana nei i ka lāʻau lapaʻau no nā poʻe maʻi me ka hana renal impaired, e alakaʻi ʻia e nānā i nā manawa maʻamau i ka pae o ka paʻakai a me ka hana i loko o ke koko serum. ʻAʻoheʻike me ka hoʻohana o ka lāʻau lapaʻau ma nā maʻi ma hope o ka hoʻololi ʻana i ka maʻi o ka maʻi.

ʻO ka hypotension arterial Symptomatic, ʻoi aku ma hope o ka pau mua o ka lāʻau, hiki ke hōʻea i nā mea maʻi me ka hoʻēmi ʻana o ke kao o ke koko a i ʻole hyponatremia, i kū mai ma muli o ka hana diuretic therapy, kāʻai me ka paʻakai a i ʻole ke kaulike a me ka luaʻi. Pono e hoʻoponopono ʻia kēlā mau kūlana ma mua o ka hoʻohana ʻana i ka lāʻau lapaʻau. Ma mua o ka hoʻomaka ʻana i ka mālama ʻana, pono e hoʻomaʻamaʻa i ka pae o ka paʻakai a me ka nui o ke kai o ka intravascular.

Kālā paʻa lua o renin-angiotensin-.

ʻAʻohe manaʻo i ka hoʻohana like ʻana o nā inhibitor ACE, angiotensin II blockor blockers a i ʻole aliskiren e hoʻonui i ka hopena o ka hypotension, hyperkalemia a hōʻemi i ka hana renal (e komo pū ana me ka hana ʻole o ka renal).

No laila, ʻaʻole hoʻolako ʻia kahi pālua o ka renin-angiotensin i ka wā e hoʻohui ai i kahi mea paʻa o ACE i kahi antagonist. Inā noʻonoʻo ʻia ka blockade ʻelua pono, pono ia e hana ma lalo o ka mākaʻi ʻana o ka poʻe loea a me ke kiaʻi mau ʻana i ka hana renal, electrolytes a me ke kahe koko.

ʻAʻole e hoʻohana ʻia nā pale o ACE a me nā blocker neʻe neurropens e hoʻohana ʻia i nā manawa like ʻole i nā mea maʻi me nephropathy maʻi.

ʻO nā kūlana ʻē aʻe e hele pū ana me ka hoʻoulu ʻana o renin-angiotensin-.

I ka poʻe maʻi e pili ana ka vascular tone a me ka hana renal i hilinaʻi i ka hana a renin-angiotensin - (no ka laʻana, i nā mea maʻi me ka hōʻeha puʻuwai hōʻeha nui a maʻi ʻole paha, a me ka stalosis renal arela), hana me nā lāʻau lapaʻau e pili pū ana i kēia ʻōnaehana. kumu i pilikia hypertension arterial, hyperazotemia, oliguria, a i ʻole ka mea maʻamau, ka maʻi renal aʻai ʻole.

ʻO ka maʻamau, ʻaʻole i pane ka poʻe maʻi me ka aldosteronism maʻamau i nā lāʻau antihypertensive e kāohi ana i ka renin-angiotensin system, no laila, ʻaʻole i kūpono ke kuhikuhi i ka telmisartan i nā mea maʻi i kēia kūlana.

ʻO ka stenosis valve Mitral a me aortic, obstract hypertrophic cardiomyopathy.

E like me nā vasodilator e pono, e mālama ʻia e mālama i ka lāʻau lapaʻau i nā mea maʻi me ka mitral a me ka stenosis aortic a i ʻole obstrate hypertrophic cardiomyopathy.

ʻO ka hoʻohanaʻana i nā lāʻau lapaʻau e pili ana i ka renin-angiotensin-aldosterone e hiki ai i ka hyperkalemia.

I nā poʻe maʻi ʻelemakule, i nā mea maʻi me ka hiki ʻole o ka pale, nā mea maʻi me ka maʻi maʻi maʻi, i nā mea maʻi e loaʻa i ka manawa i nā lāʻau ʻē aʻe e hiki ai ke hoʻonui i ke kiʻekiʻe o ka potassium a / ai ʻole i nā mea maʻi me nā maʻi hoʻomālamalama, hiki i ka maʻi hyperkalemia.

Ma mua o ka hoʻohana like ʻana o nā lāʻau lapaʻau e pāpā ana i ka ʻōnaehana renin-angiotensin-aldosterone, pono ke loiloi ka loaʻa ʻana o ka loaʻa o ka loaʻa a me ka loaʻa mai.

ʻO nā mea koʻikoʻi e pili i ka hyperkalemia e pono e mālama ʻia.

diabetes mellitus, renal gagal, makahiki (> 70 mau makahiki),

hui pū me kekahi a i ʻole he mau lāʻau e pili ana i ka ʻōnaehana renin-angiotensin-aldosterone, a me / a me nā pāpaʻa kai me nā paʻakai. ʻO nā lāʻau lapaʻau a i nā papa lāʻau lapaʻau paha e hiki ai ke hoʻonāukiuki i ka hyperkalemia ka hoʻohana ʻana i ka paʻakai paʻakai ka paʻakai, ka diuretics potassium-sparing, inhibitions ACE, angiotensin II antagonist receptor, nā lāʻau lapaʻau anti-inflammatory non-steroidal (NSAIDs, me nā poʻe koho pumehana kōkole-2), heparin a me tacrolimus immunodiamine, kopika,

nā hōʻike i waena, i ka lula, ka hoʻohiolo ʻana o ka cardiac ma mua, ka hoʻōla o ka metabolic, ka hana ʻole ʻana o ka lua, ke ʻano kūlohelohe o ka ʻōpū (nā maʻi hopohopo), nā lysis kelepona (e.g. i ka ischemia umauma mākala, rhabdomyolysis, trauma nui).

Kuhi ʻia ka mālama ʻana i ka potassium serum i nā mea maʻi ma ka hopena.

Loaʻa ka lāʻau lapaʻau i ka sorbitol (E 420), no laila ʻaʻole pono e kuhikuhi ʻia i nā mea maʻi me ka intolerance fructose hoʻoilina.

E like me ka mea i hōʻike ʻia ai ke kuhikuhi ʻana i ka inhibitor ACE, telmisartan a me nā mea ʻāwili e hoʻonele ʻia ai nā angiotensin blockers e ʻoi aku ka maikaʻi ma ka hoʻohaʻahaʻa ʻana i ke kahe koko i loko o nā poʻe maʻi o ka lāhui Negroid ma mua o nā lāhui ʻē aʻe, malia paha no ka mea ke kiʻekiʻe o ka renin i ka poʻe maʻi o ka lāhui Negroid me ka hypertension arterial i haʻahaʻa ma mua o nā mea i hōʻike ʻia. nā lāhui ʻē aʻe.

E like me nā lāʻau āpau antihypertensive, ʻo ka nui o ka hoʻemi ʻana o ke kao nui i loko o nā mea maʻi me ka maʻi puʻuwai coronary a me ka cardiopathy coronary hiki ke alakaʻi i ka hoʻomohala ʻana i ka maʻi myocardial or stroke.

Hoʻopilikiaʻia nā maʻi maʻi maʻi me ka lāʻau a i ʻole ka hypoglycemic drug.

Hiki i nā mea maʻi ke loaʻa i ka lāʻau a i ʻole ka lāʻau antidiabetic ke loaʻa he hypoglycemia. I kēia mau maʻi āpau, pono ia e hoʻomalu i ka pae o ka glucose i ke koko, a pono hoʻi e mālama pono i ka wā e hoʻoponopono ai i ka nui o ka insulin a i ʻole nā ​​mea antidiabetic.

I nā mea maʻi me ka maʻi mellitus, hiki i ke kuʻi ʻia o nā maʻi cardiovascular (nā mea maʻi me ka maʻi mellitus, me nā maʻi concomitant o nā coronary arteri), ka hopena o ka hoʻomohala ʻana i ka maʻi myocardial infalction me kahi hopena momona a me ka hopena o ka hōʻemi kuhi cardiovascular nui aʻe e kiʻekiʻe aʻe inā e mālama ʻia me nā lāʻau antihypertensive, e like me ka angiotensin IIP receptor antagonist a me nā mea paʻa. I nā maʻi me ka maʻi mellitus, ʻo ke ala o nā maʻi concomitant o nā aronona coronary e like me ka asymptomatic a no laila aia ka undiagnosed. ʻO nā maʻi maʻi me ka maʻi diabetes e nānā pono ʻia, no ka laʻana, ma o ka hoʻāʻo ʻana i ka pilikia e ʻike ai a mālama i ka maʻi ʻalā coronary conclitant ma mua o ke kau ʻana i ka lāʻau.

ʻO ka hiki ke alakaʻi i ka hopena i ka wā e lawe ana i nā kaʻa a i ʻole nā ​​hana ʻē aʻe

Ke hoʻohana nei i ka lāʻau antihypertensive, hōʻeha a hōʻalo paha ke hele i kekahi manawa. No laila, inā pono, hoʻokau i nā kaʻa a hana paha me nā mīkini ʻē aʻe e pono e noʻonoʻo ʻia.

Hoʻopili me nā lāʻau lapaʻau a me nā ʻano ʻē aʻe ʻē aʻe

Me ka hoʻohana like ʻana o ka telmisartan a me ka digoxin, piʻi ka nui o ka piʻi ʻana ma o nā peka plasma kiʻekiʻe o ka digoxin (ma 49%) a me ka nānā liʻiliʻi (ma o 20%) i nānā. I ka hoʻomaka ʻana o ka hoʻokele ʻana, ma ka hihia o ka hoʻoponopono ʻana a me ka wehe ʻana o ka telmisartan, hoʻokaʻawale ʻia nā level Digoxin e mālama ai iā lākou i loko o ka hopena therapeutic.

E like me nā lāʻau'ē aʻe e hoʻopili ai i ka ʻōnaehana renin-angiotensin-aldosterone, hiki i ka telmisartan ke hoʻoulu i ka hyperkalemia. Hiki ke hoʻonui i kēia ka hopena inā hui pū me nā lāʻau lapaʻau ʻē aʻe e hiki ai ke hoʻonāukiuki i ka hyperkalemia (pā paʻakai paʻakai i ka paʻakai, ka diuretics potassium-sparing, inhibition ACE, angiotensin II antagonist receptor, NSAIDs (e komo pū ana me COX-2 inhibitors), heparin, immunosuppressants taclosporin (cyclosporin) a me ka trimethoprim).

Hoʻokumu ka manaʻo o hyperkalemia i nā mea pili i pili i ka pilikia. Hoʻonui ka pilikia inā hoʻohana i nā hui hoʻohui therapeutic i luna. Maikaʻi nui kēia pilikia inā i hui pū ʻia me ka diuretics potassium-sparing a me nā hoʻololi o ka paʻakai e loaʻa ana i ka potassium. ʻO nā hui, no ka laʻana, me nā ACE inhibitors a i ʻole NSAIDs, e waiho ana i kahi haʻahaʻa haʻahaʻa me ka mālama koʻikoʻi inā hoʻohana.

ʻAʻole kōkua ʻia ka hoʻohana ʻana.

Me ka diuretics potassium-sparing a i ʻole e hoʻolako ai i ka mea kanu i ka paʻakai.

ʻO AI angiotensin receptor antagonist, e like me ka telmisartan, hoʻemi i ka poho potoma ma muli o ka diuretics. ʻO ka diuretics pākuhi pili, e like me spironolactone, eplerenone, triamteren a amiloride, nā mea hoʻohui meaʻai e loaʻa ana i ka paʻakai a pākolo paʻuhū paʻuhū paʻakai e hiki ke alakaʻi i ka nui o ka nui o ka nui o ka papa serum. Inā hōʻike ʻia ka hoʻohana ʻana ma muli o ka maʻi hypokalemia, pono e hoʻohana ʻia kēia mau lāʻau me ka mālama me ka mālama pinepine ʻana o ka potassium serum.

Me ka hoʻohana like ʻana o ka lithium me ka ACE inhibitors a me nā angiotensin II receptor antagonist, me ka telmisartan, kahi hoʻi hoihoi i ka hoʻohui o ka lithium plasma a me nā meaʻawaʻawa ua ʻike ʻia. Inā makemake ʻia ka hoʻohana ʻana o ia ʻano hui, mālama ʻia ka mālama ʻana i nā pae o ka serum lithium.

Hoʻohana pinepine, ʻo ia ka mea e makaʻala.

ʻO nā lāʻau anti-inflammatory Nonsteroidal.

Nā NSAID (e.g., acetylsalicylic acid i loko o kahi wai i manaʻo ʻia no ka hoʻomaʻamaʻa ʻana o nā hopena hoʻoneʻe, nā mea hoʻomehana COX-2 a me nā NSAID paʻa ʻole) hiki ke hōʻemi i ka hopena antihypertensive o kaʻōkohu antagonist reseptor II.

I kekahi mau mea maʻi me ka hana renal impaired (i nā mea maʻi me ka dehydration a i nā mea maʻi maʻi me ka hana ʻole ʻole o ka hopena), ka hoʻohana pinepine ʻana o ka antagonist reseption ngiotensin II a me nā māka e hoʻoneʻe ana i ka COX hiki ke alakaʻi hou i ka hana hou ʻana o ka hana renal, me ka hiki ʻole o ka hopena renal failed, ka mea maʻamau he pili hou. No laila, pono e hoʻokaʻawale ʻia kēlā ʻano hui, ʻoi aku hoʻi i nā poʻe maʻi ʻelemakule. Pono nā mea maʻi e loaʻa i ka lawa o ka lawa o ka wai a me ka hiki ke nānā i ka hana o ka kidney, e kaupaona ʻia ma hope o ka hoʻomaka ʻana o ka hoʻomaʻamaʻa ʻana a me kekahi manawa ma hope o ia.

ʻO kahi hoʻonui hoʻonui 2.5-pā i AUC 0-24 a me C max i hōʻike ʻia me ka hoʻohana pū ʻana me ramipril a me ramiprilat. ʻAʻole ʻike ʻia ke ʻano olakino pili o kēia leka.

Diuretics (thiazide a loop).

ʻO ka hoʻomaʻamaʻa mua me nā dosis kiʻekiʻe o ka diuretics, e like me ka furosemide (loop diuretic) a me ka hydrochlorothiazide (thiazide diuretic), hiki ke alakaʻi i ka dehydration a me ka hopena o kahi hypotension i ka hoʻomaka ʻana o ka mālama ʻana me ka telmisartan.

E noʻonoʻo pono me ka hoʻohana pū ʻana.

ʻO nā lāʻau lapaʻau antihypertensive.

ʻO ka hopena o ka telmisartan - kahi hōʻemi i ke kahe o ke koko - hiki ke hoʻonui aʻe i ka wā e hoʻohana ʻia me nā lāʻau antihypertensive ʻē aʻe.

Hāʻawi ʻia i nā waiwai pharmacological, hiki ke hoʻoholo ʻia nā lāʻau lapaʻau e like me ka baclofen, amifostine, hiki i nā hopena hypotensive o nā lāʻau antihypertensive āpau, me ka telmisartan. Hoʻopilikia nui paha ka hypthension Orthostatic ma muli o ka inu wai wai, ka hoʻohana ʻana i ka barbiturates, nā lāʻau lapaʻau a me nā antidepressants.

Hoʻololi (Cicicosteroids).

Hōʻemi i ka hopena antihypertensive.

Kālā paʻa lua o renin-angiotensin-.

Ua hōʻike ʻia ua pālua i ka blockade o renin-angiotensin- (RAAS) me ka hoʻohana pū ʻana o ka ACE inhibitors, theiotiotinin II receptor antagonists a aliskiren i hōʻike ʻia e kahi kiʻekiʻe kiʻekiʻe o nā hopena ʻino e like me ka hypotension arterial, hyperglycemia, hoʻemi i ka hana renal (e komo pū ana me ka hana ʻole) a hoʻohālikelike ʻia. ka hoʻohana ʻana o ka monotherapy.

Hoʻohana i ka wā hāpai a me ka lactation

ʻAʻole hiki ke hāʻawi ʻia ka lāʻau Telmisartan i ka wā hāpai. Inā loaʻa kekahi koi nui e hoʻomau i ka lāʻau antihypertensive, pono e kūkā i kahi kauka. ʻO ia ke koho i nā lāʻau kūpono e hoʻololi.

Inā kūpono, e hoʻohana ʻia ka hoʻohana kālā no ka mālama ʻana i nā wahine i ka wā lactation e hoʻoneʻe i ke keiki i ka hana hānai. ʻO kēia alahele no ka nele o ka ʻike e pili ana i ka hopena o ka telmisartan, aia paha i loaʻa i ka waiū, ma ke kino o nā pēpē.

Hoʻohana i ka wā kahiko

ʻO ka hoʻohana ʻana o Telsartan i ka wā ʻelemakule ʻaʻole nā ​​hiʻohiʻona o ka waiho ʻana o nā contraindications i nā maʻi.

ʻO ka hoʻohana ʻana o Telsartan i ka wā ʻelemakule ʻaʻole nā ​​hiʻohiʻona o ka waiho ʻana o nā contraindications i nā maʻi.

ʻO ke kauā o Telsartan 80

Hoʻolaha nā ʻikepili ma kahi overdose. Hiki i ke hypotension, wikiwiki a hoʻolōʻihi paha i ka puʻuwai naʻau.

Inā kānalua ʻoe i ka make nui o ka telmisartan, pono ʻoe e nīnau i ke kauka. I kēia hihia, ua noi ʻia ke ʻano hōʻailona maʻi. ʻAʻole maikaʻi kēlā Hemodialysis.

Hoʻopili pū me nā lāʻau ʻē aʻe

Hōʻola ka mea hana i ka hana o nā lāʻau antihypertensive.

ʻO ka hui pū ʻana o Telsartan me nā statins, paracetamol ʻaʻole ia e alakaʻi i ka hiʻohiʻona o nā hopena like ʻole.

Hiki i ka hāmeʻa ke hoʻonui i ka ikaika ʻoi aku ka maikaʻi o ka digoxin i loko o ke kahawai. Pono kēia i ka nānāʻana i nā ʻike.

ʻAʻole ia e kuhikuhi i ka hoʻohana ʻana iā Telsartan me ka diuretics pākeleka me ka lāʻau lapaʻau, ka mea koʻikoʻi koʻikoʻi o ia mau pāhare. ʻO kēlā hui hui hiki ke alakaʻi i hyperkalemia.

ʻO ka hui pū me nā hoʻomākaukau e pili ana i nā paʻakai lithium e hoʻonui i kā lākou pehu. ʻO ka hoʻohana ʻana i ia ʻano hui pono pono wale nō ma lalo o ke kūlana o ka mālama pono ʻana i ka ʻike lithium ma ke kahe koko.

ʻO ka acetylsalicylic acid a me nā lāʻau lapaʻau anti-radiation a hiki ke hoʻemi i ka hopena o ka lāʻau. ʻO nā NSAID e kāohi i ka hana cyclooxygenase, i hui pū me ka telmisartan, hiki ke alakaʻi i ka hana renal impaired i kekahi mau o nā mea maʻi.

ʻO ka acetylsalicylic acid a me nā lāʻau lapaʻau anti-radiation a hiki ke hoʻemi i ka hopena o ka lāʻau.

Hoʻopau nā glucocorticosteroids Systemic i ka hopena antihypertensive o ka lāʻau.

Hoʻolaha ka waipuna

ʻAʻole ia e hāʻawi i ke kī ʻana i nā ʻano kīmaha i ka wā o ka mālama ʻana me Telsartan.

ʻO nā ʻano kuʻina o kēia hāmeʻa nā:

• Mikardis,
• Koiā ʻia
• Raniopharm Telmisartan,
• Telpres
• Telmista
• ʻIke,
• Hipotel.

ʻO ka Hipotel kahi hoʻohālike o Telsartin.
ʻO Telpres kahi hoʻohālikelike o Telsartin.I waena o nā mea kikoʻī o Telsartin, hōʻike ʻia ka lāʻau Telmisartan-Ratiopharm.
Nānā Telsartin i ka lāʻau ma mua.
ʻO ka lāʻau Mikardis ka mea like me Telsartan.
ʻO Telmista kahi hoʻohālikelike o Telsarpan.